Mendelspod Podcast

54:58

September 2020 Review with Nathan and Laura: Vaccine...

Mendelspod Podcast ·

2020/10/02

We take a deep dive into a core genomics question that is somewhat philosophical today: “what is a disease, or disability?” This month we heard about a new experimental drug for dwarfism called vosoritide that raised questions for parents of dwarfism. If the drug could make their children taller, would they give it to them? Laura asks “can we put forth a medication for a condition saying those who take it are better off getting rid of it and not be saying those who are not getting it are

en

35:16

Bob Nussbaum on the State of Genetic Testing: 2020...

Mendelspod Podcast ·

2020/09/22

From a career at NIH where he was Chief of the Genetic Disease Branch to academic Chief of Medical Genetics at UCSF to his current business title of Chief Medical Officer at InVitae, Bob Nussbaum has been a central figure in the field of genetic testing. A chief among chiefs. Today he gives our State of Genetic Testing: 2020 Edition.Our approach is to ask Bob to weigh into the recent debates that have come up this past year. And they can be summarized into one question. Even one word.

en

32:56

SynBioBeta 2020 with John Cumbers

Mendelspod Podcast ·

2020/09/15

Synthetic biology was surging like perhaps no other bio-based industry when the pandemic struck, and it has had some unique weapons in its arsenal for aiding in the fight against COVID. There are the leading vaccine makers such as Moderna using synthetic biology, as well as antibody technology and CRISPR based testing. But many of the surging trends from the last year have only been made more urgent this year: small molecules, food tech, synthetic materials.Living with a pandemic is making humans

en

29:58

Mapping Intracellular Context: Garry Nolan on Spatial...

Mendelspod Podcast ·

2020/09/09

First it was all about biomarkers. Then panels of biomarkers. But biology is complicated. Why does one patient respond to an immuno therapy when another which shares the same biomarker does not?Welcome to the age of spatial biology.Garry Nolan joins us today. He's a professor in the Department of Pathology at Stanford who's career has been a journey of seeing intracellular happenings more and more in context. Check out this cool analogy from a new paper his lab put out in Cell. This is a public

en

44:56

August 2020 Review: Radical Shift on LDT Policy,...

Mendelspod Podcast ·

2020/09/01

After a long break, the world's first genomics pundits are back for the season. And they are calm and collected in the face of the strorm on Pennsylvania Ave. We're sixty days from an election. How serious should we be taking politicization of the COVID vaccine, this radical shift on LDTs at the FDA?We also discuss some regular approvals and on rejection that sent the industry reeling with disappointment. Then it's on to Laura's, Nathan's, and Theral's picks for science of the month.Welcome

en

27:03

Using CRISPR Genome Editing Tools, Willow Biosciences...

Mendelspod Podcast ·

2020/08/26

We see this new ingredient appearing advertised and in products everywhere. On the billboards, in the new shops next to our favorite restaurant, on the counters at the barbershop and when we pick up our prescriptions at the pharmacy.C-B-D.It has to do with the ongoing revolution that’s happening around the country—around the world—regarding the deregulation of marijuana. But there’s another revolution that will change our consumption of cannabinoids. That of synthetic biology. This is a public

en

29:14

The Pros and Cons of Expanded Carrier Screening with...

Mendelspod Podcast ·

2020/06/16

Mary Norton is a perinatologist and clinical geneticist at UCSF who says that in the age when we are diagnosing ever more rare diseases, adding to the carrier screening panel can be a good thing, but it’s complicated.But it can be a good thing.But it’s complicated. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

47:41

Is This A Unique Time for Science? We Ask Sci-fi...

Mendelspod Podcast ·

2020/06/13

Has this pandemic presented a unique moment for science in our history? Or is it just a strange and temporary moment of science fiction? Or both?Sci-fi author Kim Stanley Robinson (The Mars Trilogy, The Ministry of the Future) recently penned an essay in the New Yorker about how the virus has “changed our imaginations” and created a new “structure of feeling.” This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit

en

55:19

May 2020 with Nathan and Laura: Vaccine News, Notre...

Mendelspod Podcast ·

2020/06/01

Happy summertime! We had positive news this month about an mRNA vaccine from Moderna. We also saw how during a pandemic, the process of science is especially abnormal. Nathan says let's be happy about the good news. Laura's ringing with alarm bells, sensing conflicts of interest right and left. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

36:12

Matt Loose on "Read Until" or Adaptive Sequencing

Mendelspod Podcast ·

2020/05/28

Back before the world turned upside down, you know, all those years ago--early this February--a paper popped up on bioRxiv called, “Nanopore adaptive sequencing for mixed samples, whole exome capture and targeted panels." It’s an interesting paper.In the paper, the authors, led by Matt Loose from the DeepSeq lab at the University of Nottingham, describe a method unique to nanopore sequencing where one can do "selective sequencing of single molecules in real time by individually reversing the

en

33:11

The Current State of Coronavirus Vaccines with Jeff...

Mendelspod Podcast ·

2020/05/21

What is the key to getting a coronavirus vaccine? “Manufacturing,” says today’s guest, Jeff Stein of Cidara Therapeutics.Jeff joined us just last fall to talk about his company’s exciting new technology, an immunotherapy, that is a universal flu preventative and therapy. Yes, you read that right. A universal flu preventative. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

47:24

April 2020 Review with Nathan and Laura: Ioannidis...

Mendelspod Podcast ·

2020/05/01

Our commentators, Nathan Pearson of Root and Laura Hercher of Sarah Laurence College, join us to look back on month two of the first modern pandemic.We begin with a scandal that rocked the Twitter science community and talk about how science itself may be having a big moment. Will this be a silver lining for this strange year?Then it’s on to antibody testing. What would a good antibody test need to do? And will there be tough ethical questions when some “have their immunity papers” and go back to

en

29:59

Lab Director Speaks to the Challenges of COVID-19...

Mendelspod Podcast ·

2020/04/14

Why have diagnostic tests for the Coronavirus been slow on the scene? What have been the challenges for lab directors? Were they scientific? Were they regulatory? Were they scaling challenges? Are they still scaling challenges? Supply chain problems?Elaine Lyon worked for many years at the molecular genetics lab at ARUP at the University of Utah and is now the Clinical Services Lab Director at Hudson Alpha. In both of these jobs she has designed and overseen the design of many diagnostic

en

31:07

FDA in the Time of Coronavirus: Understanding the New...

Mendelspod Podcast ·

2020/04/07

After the virus reached American shores, was the FDA quick enough to allow companies and labs to develop their own tests without restrictive oversight? The question sparked a sweeping new bill in congress, the VALID Act that could overhaul FDA oversight of diagnostics altogether—something that has been clamored for for a generation.Turna Ray has been covering the FDA and diagnostics for GenomeWeb since 2006. She has recently written a piece on the new VALID Act that includes responses from various

en

53:39

March 2020 Review with Nathan & Laura: Corona Gets...

Mendelspod Podcast ·

2020/04/02

Laura comes to us from her flat in New York, Nathan is stuck in San Diego, but they are here and ready to discuss what a month ago was a warning and now is a full blown world crisis. What have they faced personally? What are their thoughts on testing? And what are some of their early big picture reactions as to how this will all go down?We make some time for some Corona-free science as well. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus

en

35:20

90% Go Undiagnosed, Says Geisinger’s Amy Sturm of FH...

Mendelspod Podcast ·

2020/03/26

More than one in two hundred people have an inherited form of heart disease. But most don’t know it.Often on Mendelspod we talk about cancer genomics, but in the area of cardio, too, genetic testing can save lives.Amy Sturm is the Director of Genomic Counseling and Screening Program at Geisinger Health Systems. There she has led the effort to return the results of cardio genetic tests to over 1,000 patients. This is a public episode. If you'd like to discuss this with other subscribers or get

en

39:21

Lisa Alderson on Her Telegenetics Firm, Genome...

Mendelspod Podcast ·

2020/03/10

Lisa Alderson has been helping to build genetic testing companies for a while. In 2016 she co-founded her own company, Genome Medical, a tele-genomics firm to help patients and providers understand genetic testing results.Anyone in the genetic testing industry will know that Genome Medical’s offering addresses a burning need. As Lisa remarks in today’s show, genetics is complicated. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes,

en

61:42

February 2020 Review with Nathan and Laura:...

Mendelspod Podcast ·

2020/02/28

What do we actually know about the novel coronavirus, we ask our two monthly commentators at the outset of February’s review show. Then, speaking of pandemics, as Bernie fever sweeps America, we explore the charge that Medicare for All means an end to innovation.Laura gives an update on the status of the genetic counseling bill, and Nathan comes to us live from AGBT with highlights from Marco Island. This is a public episode. If you'd like to discuss this with other subscribers or get access to

en

24:41

Pouria Sanae on the DTC Slowdown and His New...

Mendelspod Podcast ·

2020/02/13

“To be fully honest, I think some of these tests are scary tests. I’ve had the luxury of testing myself . . . some of this needs to have the physician and the genetic counselor involved.”That’s Pouria Sanae, a newcomer to our field via Yahoo and Helix. He’s also a Swede which gives him a fresh perspective on American genomic culture. Last month Pouria and his co-founders launched ixlayer, a new platform that integrates many of the players in the genomic medicine space: DTC companies, clinical

en

50:15

January 2020 Review: Genetic Counselors vs ACMG,...

Mendelspod Podcast ·

2020/01/31

23andMe lays off over 100 employees. Illumina comes to the JP Morgan empty-handed. Has Precision Medicine seen it’s heyday already? Or are we gearing up for another wave of innovation? Nathan and Laura are again ready for the tough questions of genomics.We begin with the current spat between genetic counselors and the ACMG. Like, . . . huh? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

All Episodes

Similar Podcasts

Mendelspod Podcast

Theral Timpson

DMCN Journal

John Wiley & Sons Ltd

汪诘：科学有故事（主打）

科学有故事

天方烨谈

基因频道

Homesteading and Permaculture by Paul Wheaton

paul wheaton